Development Portfolio

Pipeline

TitleIndicantsDevelopmental stages
CD 250Hematological malignanciesDiscovery
CD 430Antithrombotic Preclinical
CD 650Colorectal cancer Discovery
CD 010Antiplatelet agentGrant application accepted
CP 010CNS medicinePreclinical
CD 020Urinogenital organ medicinePreclinical
CD 030OsteoporosisPreclinical